Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C9orf72 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | FGD2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | SPDEF | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | CNPPD1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | S100B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | COMTD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PRY2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | APOC1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AMOTL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | VPS18 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |